Novel AI technique able to distinguish between progressive brain tumours and radiation necrosis, York University study finds

TORONTO, Dec. 8 2025 — While targeted radiation can be an effective treatment for brain tumours, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumours on a standard MRI. A new study published today led by a York University professor in the Lassonde School of Engineering found that a novel AI-based method is better able to distinguish between the two types of lesions on advanced MRI than the human eye alone, a discovery that could help clinicians more accurately identify and treat the issues.

“The study shows, for the first time, that novel attention-guided AI methods coupled with advanced MRI can differentiate, with high accuracy, between tumour progression and radiation necrosis in patients with brain metastasis treated with stereotactic radiosurgery,” says York Research Chair Ali Sadeghi-Naini, senior author of the paper and associate professor of biomedical engineering and computer science. “Timely differentiation between tumour progression and radiation necrosis after radiotherapy in brain tumours is a crucial challenge in cancer centers, since these two conditions require quite different treatment approaches.”

The study, published in the International Journal of Radiation Oncology, Biology, Physics, was conducted in close collaboration with imaging scientists, neuro-oncologists and neuro-radiologists at Sunnybrook Health Sciences Centre using data acquired from more than 90 cancer patients whose original cancer had metastasized to the brain.

Sadeghi-Naini says the incidence of brain metastasis  is rising as treatments improve and survival rates increase. Stereotactic radiosurgery (SRS), where a concentrated doses of radiation are applied to the cancer lesions only, is effective at controlling the tumours.  In up to 30 per cent of cases, SRS is not able to control the tumour and it continues to grow. Where it is successful, healthy brain tissue immediately surrounding the tumour may also die off, called brain radiation necrosis, and it can come with significant side effects.
 

Sadeghi-Naini and his colleagues introduced a 3D deep learning AI model with two advanced attention mechanisms to differentiate between tumour progression and radiation necrosis using a specialized MRI technique, called chemical exchange saturation transfer (CEST), and found that the AI was able to differentiate between the two conditions with over 85 per accuracy. Sadeghi-Naini says with a standard MRI the two conditions are accurately diagnosed about 60 per cent of the time, and with more advanced MRI techniques alone, the rate increases to about 70 per cent.

“Differentiating tumour progression and  radiation necrosis is very important — one needs more anti-cancer therapies and may need to be aggressively treated with more radiation, sometimes surgery.  The other may require observation, anti-inflammatory drugs, so getting this right is crucial for patients.”

-30-

York University is a modern, multi-campus, urban university located in Toronto, Ontario. Backed by a diverse group of students, faculty, staff, alumni and partners, we bring a uniquely global perspective to help solve societal challenges, drive positive change, and prepare our students for success. York's fully bilingual Glendon Campus is home to Southern Ontario's Centre of Excellence for French Language and Bilingual Postsecondary Education. York’s campuses in Costa Rica and India offer students exceptional transnational learning opportunities and innovative programs. Together, we can make things right for our communities, our planet, and our future.

Media Contact:

Emina Gamulin, York University Media Relations, egamulin@yorku.ca